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A fragment screen of a library of 560 commercially available fragments using a kinetic
assay identified a small molecule that increased the activity of the fungal glycoside hydro-
lase TrBgl2. An analogue by catalogue approach and detailed kinetic analysis identified
improved compounds that behaved as nonessential activators with up to a 2-fold
increase in maximum activation. The compounds did not activate the related bacterial
glycoside hydrolase CcBglA demonstrating specificity. Interestingly, an analogue of the
initial fragment inhibits both TrBgl2 and CcBglA, apparently through a mixed-model
mechanism. Although it was not possible to determine crystal structures of activator
binding to 55 kDa TrBgl2, solution NMR experiments demonstrated a specific binding
site for the activator. A partial assignment of the NMR spectrum gave the identity of the
amino acids at this site, allowing a model for TrBgl2 activation to be built. The activator
binds at the entrance of the substrate-binding site, generating a productive conformation
for the enzyme–substrate complex.
Introduction
The depletion of fossil fuel in combination with the increasing demand for energy worldwide has sti-
mulated research on alternative and sustainable energy sources. β-glucosidases (EC 3.2.1.21), which
hydrolyse β-1,4-glycosidic bonds, have received considerable attention due to their essential role in
bioethanol production from lignocellulosic (LC) biomass such as wood, agricultural residues and dedi-
cated energy crops [1]. LC biomass is composed mainly of cellulose (40–50%), in combination with
hemicellulose (25–30%) and lignin (15–20%) [1]. A mixture of enzymes catalyses cellulose degrad-
ation and comprises three categories; endoglucanases (EC 3.2.1.4), exoglucanases or cellobiohydrolases
(EC 3.2.1.91) and β-glucosidases (EC 3.2.1.21) [2,3]. Endoglucanases cleave the internal
β-1,4-glycosidic bonds of cellulose releasing small fragments. Subsequently, exoglucanases or cellobio-
hydrolases (CBH) act on the reducing and non-reducing ends resulting in short-chain
cello-oligosaccharides such as cellobiose, which are then hydrolysed into glucose by the action of
β-glucosidases [2]. However, the low activity of β-glucosidase results in the accumulation of cellobiose
and subsequent inhibition of other cellulases [4,5,6,7]. To counter these effects biomass hydrolysis
requires high concentrations of β-glucosidases, increasing the cost and reducing the efficiency of
large-scale conversions [6,7]. There is great interest therefore in identifying β-glucosidases with
improved catalytic activity and thermostability.
The fungus Trichoderma reesei (TrBgl2) produces thermostable cellulolytic enzymes, which make
them attractive targets for industrial applications [8]. The glycosyl hydrolase, TrBgl2 from this organ-
ism, belongs to the β-retaining glycoside hydrolase family 1 according to the classification of
carbohydrate-active enzymes (CAZY) [9,10]. The structure and biochemical properties of TrBgl2 have
been elucidated by Jeng et al. [11]. As shown in Figure 1, TrBgl2 adopts a (α/β)8-ΤΙΜ barrel-like fold
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as a typical member of the GH1 enzyme family [11]. The active site of the enzyme is in a 15–20 Å deep slot-
like cleft and is surrounded by negatively charged residues. The catalytic acid/proton donor is Glu165 (E165)
while the catalytic nucleophile/base is Glu367 (E367) for TrBgl2 [11]. Mutation of amino acids in the substrate
entrance region away from the active site such as P172L, L167W, T178V and P172L/F250A gave enhanced kcat/
Km values by 5.3-fold compared with the wild type (WT) [12]. Similarly, modified β-glucosidases from T. reesei
are included in cellulolytic enzyme cocktails that have been commercialised.
Although the majority of applications of fragment-based ligand discovery (FBLD) approaches focus on
enzyme inhibition, our group has previously described the identification of the first small molecule that directly
activates a glucosidase, the bacterial O-GlcNAc hydrolase from Bacteroides thetaiotaomicron (BtGH84) [13].
This provided the experience to use FBLD methods to explore the activation of TrBgl2 by small molecules. The
work reported here is the identification and validation of a novel activator of the fungal TrBgl2.
Ligand-observed NMR and thermal shift assays were used to further characterise the binding of the activator to
TrBgl2, whilst protein-observed NMR experiments combined with molecular docking were used to generate a
model to give insight into the mechanism of small molecule activation of TrBgl2.
Materials and methods
Chemicals and reagents
The fragment library was assembled as described by Schulz et al. [14], dissolved in DMSO-d6 to a con-
centration of 200 mM and quality controlled using 1H NMR spectroscopy. The library is a subset of the
Maybridge Ro3 diversity library (https://www.maybridge.com/portal/alias__Rainbow/lang__en/tabID__230/
Desktop Default.aspx). The entire library contains 2500 compounds of which 560 compounds were selected for
maximum diversity in chemical representation and higher solubility. Additional neighbours were purchased
from Chembridge and Enamine.
Cloning
The gene T. reesei (Trbgl2; AB003110) was optimised to the favoured codon usage for Escherichia coli and
synthesised by Invitrogen. The Trbgl2 gene fragment was amplified by polymerase chain reaction (PCR) with
forward 50-CCAGGGACCAGCA ATGCTGCCGAAAGATTTTCAGTGG-30 and reverse 50-GAGGAGAAGG
CGCGTTATGCTGCTGCAATCAGTTCATCAAAC-30 primers (overhangs underlined). The PCR product was
cloned into the expression vector of pET-YSBLIC3C using the NEBuilder HiFi DNA Assembly Cloning kit
(Biolabs). The resulting DNA construct pET-YSBLIC3C_Trbgl2 was sequenced and verified.
Figure 1. The crystal structure of TrBgl2.
(A) Cartoon and (B) Molecular surface representation of the TrBgl2 structure (PDB ID 3AHY) [11]. The two catalytic glutamic
acid residues of TrBgl2 are shown in yellow. The helices are shown in cyan, the strands in magenta and loops in green. The
activity-enhanced mutants are shown in red. The figures were created in PyMOL.
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The appropriate codon in the previously obtained recombinant plasmid pET-YSBLIC3C_Trbgl2 was mutated
by PCR in order to obtain the E367Q substitution in TrBgl2. The E367Q Trbgl2 gene fragment was produced
by PCR with forward 50-CCTATTTATGTTACCCAAAATGGCACCAG-30 and reverse 50-GCCATTTTGGG
TAACATAAATAGGCGGA-30 primers (overhangs underlined). The PCR product was cloned into the expres-
sion vector of pET-YSBLIC3C using a NEBuilder HiFi DNA Assembly Cloning kit (Biolabs). The resulting
DNA construct pET-YSBLIC3C_E367QTrbgl2 was sequenced and verified.
Trbgl2 and E367Q TrBgl2 expression and purification
Unlabelled protein
TrBgl2 and the mutant E367Q TrBgl2 were expressed and purified in an analogous manner to that previously
described by Jeng et al. [11].
15N Isotope-labelled TrBgl2 and E367Q TrBgl2 protein
Production of 15N-labelled TrBgl2 and E367Q TrBgl2 followed a similar protocol to the unlabelled proteins. An
overnight TrBgl2/E367Q TrBgl2 LB medium preculture from a freshly transformed colony was pelleted by cen-
trifugation at room temperature (4000 rpm, 10 min) and resuspended in baffled flasks with 0.5 L of M9
medium containing 3 g Na2HPO4, 1.5 g KH2PO4, 0.25 g NaCl, 0.5 g
15NH4Cl, 2 mM MgSO4, 100 μM CaCl2,
0.4% glucose, 5 mL Gibco MEM vitamins solution (SIGMA) and 0.5 mL trace elements solution (50 mM
FeCl3, 50 mM ZnSO4, 100 mM MnCl2, 10 mM CuSO4) and 100 mg/mL Kanamycin. Baffled flasks increase oxy-
genation of the medium during shaking for optimal protein expression. The 0.5 L M9 culture was subsequently
incubated at 30°C with shaking until the medium reached an optical density, OD600 of 0.8–1.0. The tempera-
ture was then reduced to 13°C for one hour before adding the isopropyl β-thiogalactopyranoside (IPTG) to a
final concentration of 0.5 mM. The cells were pelleted by centrifugation after incubation at 13°C overnight with
shaking at 200 rpm.
TrBgl2 and the mutant E367Q TrBgl2 were purified in an analogous manner to that previously described by
Jeng et al. [11].
15N, 13C, 2H and IVL methyl groups specifically labelled TrBgl2 protein
15N, 13C, 2H and IVL methyl groups specifically labelled TrBgl2 protein was expressed and purified in an analo-
gous manner to that previously described by Makraki (BMRB 50158) [15].
Enzyme activity assay
A fluorescent kinetic assay was performed for library screening of TrBgl2 using 500 mM
4-methylumbelliferyl-β-D-glucopyranoside (MUG) in a total volume of 150 mL per well. Compounds dissolved
in DMSO were added to each well to yield a final concentration from 1 to 2 mM. The reactions were performed
in 160 mM phosphate–citrate buffer in pH 6.0, initiated by adding 20 mL of the enzyme to give a final concen-
tration of 100 nM and were assayed at 40°C. The fluorescent 4-methylumbelliferyl release was recorded con-
tinuously at 355 nm excitation and 460 nm emission for 20 s using a BMG Labtech POLARstar OPTIMA plate
reader. Control experiments were performed to evaluate the possibility of interference from the intrinsic fluor-
escence of compounds in the library by repeating the assay in the absence of the enzyme.
AC50 measurements of fragment activators were performed using a final concentration of 100 nM protein
and 500 mM MUG with various concentrations of compounds depending on the solubility limits of each com-
pound in a total volume of 150 mL per well. Assays were carried out in a 96 well plate (Black Nunc F96
MicroWell Plates) at 40 and 45°C for TrBgl2 and CcBglA, respectively, in 160 mM phosphate–citrate buffer in
pH 6.0 and 2.5% DMSO. Reactions were initiated by the addition of 20 mL of protein to a final concentration
of 100 nM, followed by 5 s of shaking. The fluorescent 4-methylumbelliferyl release was recorded continuously
at 355 nm excitation and 460 nm emission for 20 s using a BMG Labtech POLARstar OPTIMA plate reader.
Rates were calculated using GraphPad Prism 5.0 as the slope of the curve of the collected data. Corrections
were made to the detected gradients to adjust for the inner filter effect of MUG and convert the gradients into
units of mmol min−1 according to a standard curve for MUG. The initial slopes were fitted to sigmoidal
dose-response curves using GraphPad Prism 5.0 and the AC50 values extracted. Inhibition of TrBgl2 by isofago-
mine (IC50) was determined in similar manner to the AC50 values.
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Apparent KM and kcat values were calculated from a Michaelis–Menten curve fit to 9-point substrate titra-
tions at a constant concentration of compounds. The covariation experiments used the same range of substrate
concentrations across an activator and inhibitor concentration range. The data obtained from these experiments
was fit to the nonessential activator and mixed-model inhibition equation, respectively.
Thermal shift assay (TSA)
Thermal shift screens were performed in 96-well polypropylene PCR plates (Agilent 401334) with a final
volume 25 mL/well. Well components were E367Q TrBgl2 (300 nM), SYPRO orange dye (8X), DMSO (5.2%),
substrate, MUG (4 mM) and compound at 4 mM in the same buffer as used for the enzymatic assays. Melting
data were collected using an Agilent Stratagene Mx3005P rtPCR machine ramping from 25 to 95°C at 30 s per
degree. Data were analysed with a combination of the Agilent MxPro software, MTS [16], JTSA (http://
paulsbond.co.uk/jtsa) and the DSF analysis spreadsheet in Excel [17].
NMR spectroscopy
All NMR experiments were collected at 298 K on a Bruker Avance Neo 700 MHZ spectrometer equipped with a
triple-resonance cryogenic probe. Data were processed using Topspin 3.2 (Bruker) and analysed with Sparky [18].
STD NMR
The samples contained 20 mM unlabelled TrBgl2, fragments at a concentration of 500 mM per compound and
100 mM sodium trimethylsilylpropanesulfonate (DSS) in 50 mM phosphate buffer containing 25 mM NaCl and
5% D2O at pH 6.0. The experiments were recorded by using a Bruker standard pulse sequence (stddiffesgp.3
[19]). The on-resonance frequency was set to 0.25 ppm and off-resonance irradiation was applied at 40 ppm.
STD NMR spectra were collected with a total of 16 scans (NS), 5 s delay between the scans (d1), a saturation
time of 4 s (d20) and 1.5 s acquisition time (AQ).
NMR titrations
For backbone chemical shift perturbations (CSPs), each sample was prepared with 120 mM 15N isotope-labelled
TrBgl2 or E367Q TrBgl2, 8 mM or 16 mM of compound 8 or 10, 5 mM of MUG substrate and 100 mM DSS
in 50 mM TRIS buffer containing 100 mM NaCl and 10% D2O at pH 8.0. The final DMSO concentration was
usually not above 3.8%(v/v). 1H-15N TROSY spectra of the enzyme with DMSO in the buffer were collected as
controls. 1H-15N TROSY spectra were collected by using a Bruker standard pulse sequence (trosyetf3gpsi
[20,21]) with 128 scans (NS), 1.5 s delay between the scans (d1), 35 ppm spectra width (SW), 256-time domain
data size (TD) and 117 ppm irradiation carrier frequency offset (O1P).
For IVL methyl group CSPs, each sample was prepared with 250 mM of 15N, 13C, 2H and IVL methyl group
specifically labelled TrBgl2, 8 mM of compound 8, in 50 mM TRIS buffer containing 100 mM NaCl and 10% D2O
at pH 8.0. The final DMSO concentration was usually not above 3.8% (v/v). 1H-13C HSQC spectra of the enzyme
with DMSO in the buffer were collected as controls. 1H-13C HSQC spectra were recorded by using a Bruker stand-
ard pulse sequence (hsqcctetgpsp [22]) with 8 scans (NS), 1.5 s delay between the scans (d1), 30 ppm spectra
width (SW), 256-time domain data size (TD) and 15 ppm irradiation carrier frequency offset (O1P).
Protein–ligand docking
The HADDOCK (High Ambiguity Driven DOCKing) Web server [23,24] used 1000 protein structures for
initial rigid-body docking solutions. The best 200 solutions based on their intermolecular energy were used for
a semi-flexible refinement. After initial docking iterations, a final explicit solvent refinement was performed on
all 200 models which then clustered based on root mean square deviation criteria. Analysis of HADDOCK
scores was performed to select the best docking solutions. HADDOCK calculations were driven by the available
CSPs recorded after binding of compound 8 to TrBgl2. Three-dimensional (3D) conformations of the substrate,
MUG and ligand (8) were generated using SMILES [25] as input.
Results and discussion
Library screening
A 560 compound (<250 Da) fragment library was screened in an enzymatic assay using 4-MUG as a substrate.
In the initial screen, one compound (1) enhanced the ability of TrBgl2 to cleave MUG (Figure 2A). Kinetic
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characterisation of the hit compound using MUG as substrate showed an activation of TrBgl2 with Amax and
AC50 value of ∼155% and 1 ± 2 mM, respectively (Figure 2B; Amax =maximal activation obtained, AC50 = con-
centration of compound eliciting 50% of maximal activation), whilst Michaelis–Menten analysis of 1 yielded an
approximately 2-fold improvement in kcat/KM values (Figure 2C; kcat = catalytic rate constant, KM =Michaelis
constant).
Ligand-observed NMR spectroscopy was used for binding characterisation of the hit compound (Figure 3).
Hit compound (1) showed evidence of binding to the enzyme in saturation transfer difference (STD) NMR
[19]; binding was also observed in the presence of the known glycoside hydrolase inhibitor isofagomine (2)
A B
C
Figure 2. Compound 1 activates TrBgl2.
(A) Chemical structure of the initial hit (1) identified by fragment screening. (B) MUG cleavage assay AC50 curve for 1.
Substrate concentration = 500 μM. (C) MUG cleavage assay Michaelis–Menten plot for TrBgl2 in the absence and presence of 1.




Figure 3. Compound 1 binds to TrBgl2.
(A) 1D proton reference spectrum of 1. (B) STD NMR spectrum of 1 (500 mM) in the presence of TrBgl2 (20 mM) and (C) the
STD NMR spectrum of the same sample following the addition of isofagomine (2) (40 mM).
© 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY). 4387























































































with an IC50 value of 0.53 ± 0.12 μM (Supplementary Figure S1). This allowed the categorisation of the hit
compound as non-competitive with isofagomine and suggested that binding must occur at an allosteric site.
To improve upon the initial hit, commercially available analogues of compound 1 were identified through an
‘analogue-by-catalogue’ approach. Many these analogues gave an increased activation of TrBgl2. Replacement
of the thiourea group by urea or thio-amide yielded an inactive analogue. Other available compounds that
retained the thiourea moiety but had a methyl group in the meta or para (rather than ortho) position were also
inactive. As summarised in Table 1, groups other than methyl (such as chloro, methoxy) ortho to the thiourea
also yielded active compounds (Supplementary Figure S2). Groups at the ortho position twist the aryl ring out
of the plane to avoid steric clashes. This twist of aryl ring might be essential for the activation of TrBgl2 and
could explain why compounds that had a group meta or para instead of ortho appeared to be inactive.
Attempts to alter the morpholino moiety were more successful and led to more active compounds. Compound
8 retains the important thiourea and the ortho methyl group generating an activator of TrBgl2 with signifi-
cantly improved Amax up to 188% in comparison with 1 and the other analogues identified. Compound 8 also
had improved solubility (up to 16 mM) compared with other tested compounds and therefore was taken
forward for further characterisation. Interestingly, one of the fragment analogues (10) that retains the thiourea
but does not have ortho substituents appears to be a potent TrBgl2 inhibitor with an IC50 value of 312 ± 32 μΜ
(Table 2). Evidence of fragment binding was also observed by STD NMR with a clear signal intensity for both
compound 8 (Supplementary Figure S3) and 10 (Supplementary Figure S4) in the presence and absence of
Table 1. Activation of TrBgl2 by analogues of compound 1




















1Maximum activation obtained with a titration of compound from 30 mM to 3.8 mM
(substrate conc. = 500 mM);
2Maximum activation obtained with a titration of compound from 63 mM to 8 mM
(substrate conc. = 500 mM).
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isofagomine (2). NMR experiments were also attempted to characterise further the orientation of 8 binding; the
difference in peak intensities in the STD measurements were not consistent enough for epitope mapping and
an NOE experiment was unable to detect any intermolecular NOEs, probably because of the weak affinity of
binding.
Kinetic characterisation
The kinetics of TrBgl2 activation revealed a nonessential activation model [26], similar to a reversible mixed
inhibition model in which the compound displays binding affinity for both the free enzyme and the enzyme–
substrate complex. In the nonessential type activation model, the dissociation constant of the substrate and acti-
vator are modified in the presence of activator and substrate respectively by the constant α. In addition, the kcat
of the enzyme in the presence of an activator is modified by the constant. Values for the α and β modifiers
were calculated as 0.64 and 1.5, respectively, for activator 8. The change in substrate binding and catalytic rate
constant reflects an approximately 1.5-fold enhancement of substrate affinity and an increase of kcat in the pres-
ence of activator 8 (Figure 4). Therefore, both values contribute to an enhanced catalytic rate through the
enzyme–substrate–activator complex.
Inhibitor 10 has an influence on enzyme kinetics that is consistent with a reversible mixed inhibition model.
In this situation, two dissociation constants are defined, one for the binary enzyme–inhibitor complex (KI) and
one for the ternary enzyme–substrate–inhibitor complex (αkI). The modifier α was calculated as 3.65 for inhibi-
tor 10 which indicates an increased dissociation constant for the MUG substrate in the presence of 10
(Supplementary Figure S5).
Thermal shift assay (TSA)
To investigate the possible role of the substrate (MUG) in fragment binding, an inactive mutant TrBgl2 was
generated (E367Q TrBgl2). The influence of fragment binding on E367Q TrBgl2 stability was assessed by TSA,
measuring the melting temperature (Tm) with and without the substrate (MUG) (Figure 5). Both 8 and 10
destabilise apo E367Q TrBgl2, decreasing the Tm by ∼1 and 4°C, respectively. In contrast, the destabilising
effect of 8 is significantly diminished in the presence of MUG (Tm increases by ∼1.2°C) whereas the addition
of MUG does not affect the significantly large destabilising effect on E367Q TrBgl2 caused by 10 (Tm decreases
Table 2. Inhibition of TrBgl2 by compound 10.
Compound Chemical structure IC50 (mM) Maximum inhibition (%)
10 312 ± 32
1
961
1Maximum activation obtained with a titration of compound from 63 mM to 8 mM (substrate conc. = 500 mM)
Figure 4. Covariation curve fits to the nonessential activator model for activator 8.
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by ∼4°C). This further suggests a contribution of the substrate to fragment binding as the activator affects
enzyme activity.
Selectivity
The bacterial β-glycosidase Clostridium cellulovorans (CcBglA) is homologous to the fungal TrBgl2 sharing 54%
sequence similarity (Supplementary Figure S6). None of the fragments activated CcBglA demonstrating that the
effect is specific. Interestingly, 10 inhibited both enzymes to a similar degree (Supplementary Figure S7).
NMR chemical shift perturbation (CSP) experiments
Although the apo structure of TrBgl2 is known (PDB ID 3AHY) [11], extensive efforts to obtain a crystal struc-
ture of 8 bound to either TrBgl2 or E367Q TrBgl2 with or without MUG were not successful. We have previ-
ously reported the sequential backbone and IVL methyl group partial assignment of the 55 kDa apo TrBgl2
(BMRB 50158) [15]. Therefore, NMR spectroscopy was used to generate information on the binding site of the
activator.
First, we investigated the effect of 8 and 10 binding to the protein by recording a 2D 1H-15N TROSY spec-
trum in the presence and absence of the compounds. The quality of apo TrBgl2 1H-15N TROSY spectrum
obtained, with well-dispersed peaks, is unusually good for such a large protein. Following addition of 8 at 8
and 16 mM some changes in amide chemical shifts occurred across the protein, indicating a specific binding
event (Figure 6A,B). Backbone 1H-15N TROSY CSPs are limited by the fact that most ligand–protein interac-
tions are mediated by sidechains which are distant from the detected backbone amides. Therefore, a sample of
deuterated TrBgl2 with Ile, Val and Leu (IVL) sidechain methyl groups protonated was produced. A constant-
time (CT)-[1H-13C HSQC] spectrum was recorded on this sample in the presence and absence of 8. Following
the addition of 8 at 8 mM, several methyl CSPs were observed reconfirming the binding of 8 to TrBgl2
(Figure 6C).
CSPs were detected on titration with compound 8 and previously determined assignments [15] allowed
some to be mapped onto the known crystal structure of TrBgl2 (PDB ID 3AHY) (Figure 6E,F). Τhe assignment
was not complete [15] but it was sufficient to reveal defined patches of interaction between 8 and TrBgl2, con-
sistent with a specific binding event at the entrance of the active site. Although most of the CSPs are located at
the substrate entrance, residues at the surrounding part of the active site such as D22, G27, T33, S46, Y130 and
Y440 are also significantly affected, potentially indicating that conformational changes in the protein are asso-
ciated with binding of activator 8. The addition of 10 at 8 mM caused smaller but similar changes as seen for 8
Figure 5. Maximum shift in melting temperature from reference (ΔTm) for selected compounds and MUG.
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(Supplementary Figure S8). Due to solubility issues 1H-15N TROSY spectra of 10 at a concentration higher
than 8 mM were not recorded.
The possible role of substrate in fragment binding was further investigated by 1H-15N TROSY NMR using






Figure 6. NMR analysis of compound 8 binding to TrBgl2.
(A) 1H-15N TROSY spectrum (700 MHz, 298 K) of apo TrBgl2 (blue) overlaid with spectra of TrBgl2 with 8 at 8 mM (green) and
16 mM (magenta). The peaks corresponding to selected backbone amide groups are indicated. (B) Expanded panel of 1H-15N
TROSY spectrum. Red arrows indicate the direction of chemical shifts on increasing ligand concentration for selected amino
acids. (C) CT 1H-13C HSQC spectrum of an IVL methyl protonated sample (700 MHz, 298 K) of apo TrBgl2 (purple) overlaid
with spectrum of TrBgl2 with 8 at 8 mM (red). Spectra collected under identical conditions. (D) Weighted backbone and methyl
CSPs induced by 8; the dashed line is the experimentally determined significance threshold. (E) Assigned backbone and IVL
methyl CSPs caused by the presence of 8 mapped onto the crystal structure of TrBgl2 (PDB ID 3AHY). Assigned backbone
and methyl CSPs are coloured green and blue respectively. Unassigned residues are coloured grey. The protein backbone is
shown as a ribbon diagram in cyan. (F) The above backbone and IVL methyl CSPs mapped on the protein surface, shaded as
in (E). The figure was created in PyMOL.
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fully folded protein, the resonances were broadened compare to the WT TrBgl2 spectra. Following the addition
of MUG at 5 mM and 8 at 8 mM, the substrate-specific chemical shifts were further enhanced indicating the
interaction site remains the same in the ternary complex. Moreover, the magnitude of the substrate-specific
chemical shifts is larger in the ternary complex E367Q TrBgl2–MUG-8 complex (Figure 7), compared with the
binary E367Q TrBgl2–MUG complex, suggesting that more enzyme is in complex with the substrate.
Therefore, considering that the conditions and concentration of MUG were kept identical, these results also
indicate higher substrate affinity to the enzyme in the presence of 8. On the other hand, following the addition
of 10 at 4 mM, the substrate-specific chemical shifts were degraded which suggests lower substrate affinity to
the enzyme in the presence of 10 (Supplementary Figure S9). Both observations are in full agreement with the
kinetic experiments.
TrBgl2–8-MUG complex structure
The crystal structure of the closely related NkBgl–E193D in complex with pNPG was used to generate models
of the TrBgl2–MUG and TrBgl2–8-MUG complexes (PDB ID 3IA0) [11] using the program HADDOCK
[23,24]. After binding of the substrate (pNPG) to the inactive NkBgl–E193D, significant changes in the struc-
ture occur at the side chains of residues Glu/Asp193, Asp253, Trp374, Trp444, Asn449 and Glu451 [11]. The
substrate pNPG was observed to form direct hydrogen bonds to Gln45, His148, Asn255, Glu402, Trp444,
Glu451 and Trp452 of NkBgl–E193D. A structural alignment suggests that these residues in NkBgl are equiva-
lent to Gln16, His119, Asp227, Glu367, Trp417, Glu424 and Trp425 of TrBgl2 (Supplementary Figure S10).
The equivalent hydrogen bonding interactions between NkBgl and pNPG can therefore be used as restraints to
model the structure of the TrBgl2–MUG complex (Supplementary Figure S10) using HADDOCK. Asp227, the
amino acid that directly interacts with the nitrophenyl part of the substrate, pNPG, was excluded. The
HADDOCK calculations generated a single cluster (Model 1) which exhibited a HADDOCK score of −60 and
a minimum restraint violation energy of 1.1 kcal/mol (Supplementary Figure S11).
Next, HADDOCK was also used to generate a model of 8 docked into the TrBgl2–MUG cluster using model
1, the chemical structure of 8 and the most significant backbone amide and methyl CSPs as ambiguous
restraints (assigned as backbone CSPs: G175, S176, T178, F179, G226, M295, N296, N301, W339 and W425;
IVL methyl group CPSs: L167, I171, V316 and V321). Because the NMR experiments did not provide sufficient
information for epitope mapping or intermolecular NOEs, there is insufficient information to define an orien-
tation for the ligands. However, the HADDOCK calculations generated two clusters indicating the region
where the ligand binds. The lowest energy cluster (Model 2) exhibited a HADDOCK score of −19.5 and a
minimum restraint violation energy of 35.4 kcal/mol, whereas the next ligand cluster (Model 3) exhibited a
HADDOCK score and minimal restraint violation energy of −8.1 and 72.1 kcal/mol, respectively. Both models
suggest that the binding site of 8 is at the substrate entrance of TrBgl2 with a direct contact between activator 8
A B
Figure 7. NMR TROSY spectra of 8 and MUG binding to E367Q TrBgl2.
(A) 1H-15N TROSY spectrum (700 MHz, 298 K) of apo E367Q TrBgl2 (black) overlaid with spectrum of E367Q TrBgl2 with MUG
at 5 mM concentration (orange) and spectrum of E367Q TrBgl2 bound with both MUG and 8 at 5- and 8-mM concentration,
respectively (green). (B) Expanded panel of representative portion of the overlaid spectra. Red arrows indicate the direction of
chemical shifts. Spectra collected under identical conditions.
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and MUG (Figure 8). The binding of 8 seems to close the active site entrance, trapping the bound substrate
resulting in a more suitable orientation for enzyme activity. Interestingly, the previously identified mutations
that lead to enhanced activity of TrBgl2, such as L167W and T178V [12] are clustered at the same site where
the TrBgl2 activator interacts.
The pattern of mapped CSPs of 10 is quite similar to that of 8 indicating that the two compounds bind in
the same binding site (Supplementary Figure S8). It is not clear why 10 is an inhibitor — a possible explan-
ation that is consistent with the kinetic models and the TSA measurements is that 10 significantly destabilises
binding of the substrate generating a less productive conformation for enzyme activity. This switch between
activation and inhibition with just small modifications of the compound has been observed in other systems,
such as for resveratrol-like compounds on sirtuin [27] and in compounds that modulate the interaction
between KRas and SOS [28].
Conclusion
We have used fragment-based methods to identify a selective, small molecule compound that increases the
activity of the industrial glycoside hydrolase, TrBglA by 188%. Structure–activity relationship (SAR) of closely
related compounds suggest that activation is achieved by substituents inducing a particular conformation on
the activators which results in a productive conformation for the enzyme–substrate complex; a closely related
compound that was unable to achieve such a conformation was an inhibitor. This work would need to be
extended to the covalent linkage of the activators (as previously demonstrated for BtGH84, [29]) to generate
enzymes that could feasibly be used for industrial applications. However, it does demonstrate an alternate
approach to traditional genetic approaches for generating enzymes with improved activity.
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Figure 8. Structural model of compound 8 binding to TrBgl2.
Overlays of the lowest energy HADDOCK model structures of 8 docked with TrBgl2–MUG complex using the backbone amide
and methyl CSPs interpreted to locate at the TrBgl2’s active site. The figure was created in PyMOL.
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